Small bioactive peptides (16-38 amino acids) encoded by open reading frames within mitochondrial ribosomal RNA genes (12S and 16S rRNA) that function as endocrine hormones, cytoprotective signals, and metabolic regulators. The primary MDPs—MOTS-c, Humanin, and SHLP1-6—coordinate systemic metabolism, insulin sensitivity, cellular stress resistance, and longevity through nuclear gene regulation and multi-receptor signaling cascades.
Imagine mitochondria as ancient fortress libraries that don't just store energy blueprints—they also print emergency broadcast leaflets. When the fortress experiences siege conditions (metabolic stress, exercise, fasting), specialized printing presses hidden in the library's reference section (the 12S and 16S rRNA genes—areas traditionally thought to only make ribosomal parts) activate and produce crisis-specific pamphlets (MDPs).
MOTS-c is the "metabolic efficiency bulletin" that travels to City Hall (the nucleus) during energy shortages, posting new regulations on how to use glucose more efficiently—bypassing the usual insulin permit system. Humanin is the "cell survival manual" distributed to neighborhoods under oxidative attack, binding to multiple community centers (CNTFR, WSX-1, gp130 receptors) with instructions on how to resist apoptosis and improve insulin response. The six SHLP1-6 pamphlets are specialized guides for different mitochondrial functions—each addressing specific aspects of metabolic adaptation.
Unlike regular hormones produced in dedicated glands, these are guerrilla communication molecules from your cellular energy plants—proof that mitochondria aren't just power stations but independent information centers that can override central command when survival demands it.
Encoding and Release:
- Encoded by mitochondrial 12S rRNA gene (mt-RNRI) as a 16-amino-acid peptide
- Translated on mitochondrial ribosomes → released into cytoplasm → enters bloodstream
- Under metabolic stress (exercise, fasting, cold), transcription increases 3-5 fold
Metabolic Signaling Cascade:
graph TD
A[MOTS-c peptide] --> B[Cytoplasmic action]
A --> C[Nuclear translocation]
B --> D[AMPK activation]
D --> E[Inhibits ACC]
E --> F["↓ Malonyl-CoA"]
F --> G["↑ Fatty acid oxidation"]
D --> H[GLUT4 translocation]
H --> I[Insulin-independent glucose uptake]
C --> J[Stress-responsive elements]
J --> K[Upregulates antioxidant genes]
J --> L[Upregulates metabolic flexibility genes]
D --> M["PGC-1α activation"]
M --> N[Mitochondrial biogenesis]
- MOTS-c → AMPK phosphorylation (Thr172) → ACC inhibition → reduced malonyl-CoA → CPT1A derepression → enhanced fatty acid oxidation
- MOTS-c → GLUT4 translocation independent of AKT pathway → insulin-independent glucose uptake in muscle tissue
- During metabolic stress, MOTS-c translocates to nucleus → binds stress-responsive nuclear DNA elements → activates transcription of genes regulating glucose metabolism, folate cycle (ALDH1L2, MTHFD2)
- Activates PGC-1α → mitochondrial biogenesis and enhanced metabolic flexibility
Encoding and Release:
- Encoded by mitochondrial 16S rRNA gene (mt-RNRI2) as a 24-amino-acid peptide
- Multiple bioactive forms exist (HN, HNG with glycine extension—most potent)
- Constitutively expressed but increases 2-4 fold with mitochondrial stress
Multi-Receptor Cytoprotection:
graph TD
A[Humanin] --> B[CNTFR/WSX-1/gp130 complex]
A --> C[FPRL1/2]
A --> D[TREM2]
B --> E[JAK-STAT activation]
E --> F[Anti-apoptotic gene expression]
F --> G["↑ Bcl-2, ↓ Bax"]
B --> H[PI3K/AKT activation]
H --> I[Phosphorylates Bad]
I --> J[Prevents cytochrome c release]
C --> K[MAPK signaling]
K --> L[ERK1/2 activation]
L --> M[Cell survival programs]
B --> N[IRS-1 phosphorylation]
N --> O[Enhanced insulin signaling]
A --> P[Binds IGFBP-3]
P --> Q[Modulates IGF-1 activity]
- Humanin → CNTFR/WSX-1/gp130 receptor complex → JAK-STAT activation → upregulation of anti-apoptotic proteins (Bcl-2, Bcl-xL) and downregulation of pro-apoptotic Bax
- Humanin → CNTFR complex → PI3K/AKT pathway → phosphorylation of Bad (Ser136) → Bad sequestration by 14-3-3 proteins → prevents Bax oligomerization → blocks mitochondrial outer membrane permeabilization
- Humanin → FPRL1/2 (formyl peptide receptor-like) → MAPK pathway (ERK1/2) → neuroprotection and reduced inflammatory cytokine production
- Humanin → IRS-1 phosphorylation enhancement → improved insulin receptor substrate signaling → enhanced glucose uptake and insulin sensitivity
- Humanin binds IGFBP-3 → prevents IGFBP-3-induced apoptosis → enhances IGF-1 pro-survival signaling
- In neurons: Humanin → prevents Aβ-induced neurotoxicity by stabilizing calcium homeostasis and reducing Oxidative Stress
- Six small humanin-like peptides (18-38 amino acids) encoded by 16S rRNA region
- SHLP2 and SHLP3 → enhance mitochondrial respiration → increase oxygen consumption rate by 15-25%
- SHLP2 → reduces apoptosis in response to oxidative stress → mechanism involves STAT3 pathway modulation
- SHLP6 → improves insulin sensitivity in adipocytes through unclear receptor mechanisms
¶ Regulation and Secretion
- MDP expression increases with:
- MDPs decline with:
¶ Diagnostic and Prognostic Value
MDPs serve as biomarkers of mitochondrial health and metabolic resilience—patients with low circulating Humanin (<200 pg/mL) show increased risk for Alzheimer's Disease (2.3-fold), cardiovascular disease (1.8-fold), and Type 2 diabetes (2.1-fold). MOTS-c levels decline progressively with age and correlate inversely with insulin resistance (HOMA-IR), making it a candidate marker for mitoresilience status.
In the Mitochondrial Information Processing System model, MDPs represent the transduction output—the mitochondria's endocrine communication to the rest of the body signaling metabolic state, stress exposure, and adaptive capacity. Low MDP levels indicate impaired Mitochondrial Information Processing System → reduced capacity for mitohormesis → accelerated aging and disease susceptibility.
MDPs reconcile competing demands of the selfish brain and selfish immune system:
- selfish brain: MOTS-c ensures glucose availability independent of insulin, protecting neuronal fuel supply during metabolic stress
- selfish immune system: Humanin modulates inflammatory resolution—prevents excessive immune activation that would drain energy reserves while maintaining pathogen defense
- Muscle-Fat axis: MDPs coordinate energy partitioning—MOTS-c promotes muscle glucose uptake while Humanin enhances adipocyte insulin sensitivity
The MDP decline with modern lifestyles represents a critical mismatch:
- Ancestral context: Daily physical activity, periodic fasting, temperature variation → sustained MDP expression → metabolic flexibility and stress resistance
- Modern context: Sedentary behavior, constant feeding, thermoneutral environments → MDP suppression → insulin resistance, inflammaging, metabolic syndrome
This is evolutionary stress deprivation—the absence of stimuli that ancestrally maintained MDP production leads to mitochondrial dysfunction and loss of metabolic flexibility.
Lifestyle Interventions to Boost MDPs:
- exercise: High-intensity interval training increases MOTS-c 2.5-fold acutely; resistance training enhances Humanin expression in muscle
- Intermittent fasting: 16:8 time-restricted eating elevates MOTS-c 40-60% chronically
- cold exposure: Cold water immersion (14°C, 11 minutes weekly) increases MDPs via brown adipose tissue activation
- caloric restriction: 20-30% reduction increases all MDPs—mimics ancestral feast-famine cycles
Pharmacological Mimetics (emerging):
Clinical Red Flags:
- Patients with treatment-resistant Type 2 diabetes despite medication compliance—consider MDP deficiency
- Accelerated cognitive decline with metabolic syndrome—check inflammatory markers and consider Humanin insufficiency
- Exercise intolerance with normal cardiac function—may indicate impaired MDP response to physical stress
- Metamodel 1 (Perception-Reality): MDPs alter metabolic "reality" independent of insulin—nuclear translocation of MOTS-c during stress creates new metabolic programs
- Metamodel 3 (Intermittent Living): MDP expression REQUIRES intermittency—continuous feeding suppresses the stress signals that trigger MDP production
- Metamodel 5 (Evolutionary Biology): MDPs are molecular fossils—ancient mitochondrial genes repurposed as endocrine messengers, reflecting the endosymbiotic origin of mitochondria
- MOTS-c is exactly 16 amino acids encoded by a hidden reading frame in the mt-RNRI gene previously thought to only code for ribosomal RNA components
- Humanin levels in centenarians are 2-3 times higher than age-matched controls—suggesting MDP abundance correlates with extreme longevity
- MOTS-c can bypass insulin resistance entirely—activates GLUT4 translocation through AMPK rather than AKT pathway, making it a "metabolic reset" molecule
- Exercise increases circulating MOTS-c from baseline ~100 pg/mL to 250-300 pg/mL within 30 minutes of high-intensity activity
- Humanin binds seven different receptor systems (CNTFR, WSX-1, gp130, FPRL1, FPRL2, TREM2, IGFBP-3)—unprecedented promiscuity for a peptide hormone
- Alzheimer's patients show 30-50% lower Humanin levels in cerebrospinal fluid before clinical symptoms emerge—potential early biomarker
- SHLP2 increases mitochondrial oxygen consumption by 23% in cultured cells—more potent than many pharmacological metabolic enhancers
- MDPs are co-released with cell-free mitochondrial DNA during mitochondrial stress—both serve as mitokines but with opposite inflammatory effects (cf-mtDNA pro-inflammatory, MDPs anti-inflammatory)
- MOTS-c has a natural K14Q polymorphism (rs1537373) that occurs in ~10% of East Asian populations and associates with improved healthspan and reduced obesity risk
- Caloric restriction increases Humanin expression in skeletal muscle by 60% within 4 weeks—one mechanism underlying CR's metabolic benefits
- MOTS-c directly enters the nucleus during metabolic stress and binds DNA at ARE (antioxidant response elements) and MRE (metal response elements)
- Obese individuals with Type 2 diabetes have 40% lower MOTS-c and 35% lower Humanin compared to lean controls with matched age
- Humanin protects cardiomyocytes from ischemia-reperfusion injury by preventing calcium overload and reducing ROS generation by 45%
- Mitochondrial Information Processing System — MDPs are the primary endocrine output of Mitochondrial Information Processing System, signaling mitochondrial metabolic state systemically
- mitokines — MDPs constitute a specific class of mitochondrial signaling molecules alongside FGF21, GDF15, and mitochondrial ROS
- MOTS-c — the metabolic MDP that enhances glucose uptake, activates AMPK, and translocates to nucleus during stress
- Humanin — the cytoprotective MDP with anti-apoptotic, insulin-sensitizing, and neuroprotective functions
- cell-free mitochondrial DNA — co-released with MDPs during mitochondrial stress but with opposite effects: cf-mtDNA triggers inflammation via TLR activation while MDPs suppress inflammation
- mitohormesis — MDPs are key mediators of mitohormetic adaptation—low-dose mitochondrial stress increases MDP expression to enhance resilience
- mitoresilience — MDP levels directly reflect mitochondrial adaptive capacity and predict recovery from metabolic challenges
- insulin resistance — MDPs improve insulin sensitivity through AKT pathway enhancement (Humanin) and insulin-independent GLUT4 activation (MOTS-c)
- AMPK — MOTS-c directly activates this master metabolic sensor, mimicking effects of exercise and caloric restriction
- exercise — physical activity is the most potent stimulus for MDP expression, increasing MOTS-c 2-3 fold and Humanin 40-60%
- Intermittent fasting — time-restricted eating and fasting protocols elevate MDPs by creating intermittent metabolic stress
- Type 2 diabetes — reduced MDP production contributes to disease pathophysiology; MDP supplementation improves glycemic control in animal models
- Alzheimer's Disease — low Humanin levels predict neurodegeneration; Humanin prevents Aβ-induced neurotoxicity and tau hyperphosphorylation
- aging — progressive decline in all MDPs with age (30-50% reduction by 70 years) contributes to loss of metabolic flexibility and mitochondrial dysfunction
- cardiovascular disease — low Humanin levels predict adverse cardiovascular events; Humanin protects against ischemia-reperfusion injury
- neuroprotection — Humanin protects neurons from oxidative stress, excitotoxicity, and Aβ toxicity through multiple anti-apoptotic pathways
- Oxidative Stress — MDPs provide cellular protection by upregulating antioxidant defenses (MOTS-c nuclear action) and preventing ROS-induced apoptosis (Humanin)
- inflammation — Humanin reduces inflammatory cytokine production through MAPK pathway modulation and STAT3 signaling
- metabolic flexibility — MDPs enhance the ability to switch between glucose and fatty acid oxidation, essential for metabolic health
- longevity — centenarians have 2-3 times higher MDP levels than age-matched controls, suggesting causative role in extreme lifespan
- metainflammation — MDPs counter metabolic inflammation by improving insulin sensitivity and reducing adipose tissue inflammatory signaling
- brown adipose tissue — cold exposure increases MDP production via BAT activation, linking thermogenesis to metabolic signaling
- PGC-1α — MOTS-c activates this master regulator of mitochondrial biogenesis, increasing mitochondrial density and function
- nuclear gene expression — MOTS-c uniquely translocates to nucleus during stress and directly regulates transcription of metabolic genes
- mitochondrial dysfunction — MDP release signals mitochondrial stress state; low MDPs indicate impaired mitochondrial communication capacity
- evolutionary stressors — MDPs evolved to respond to ancestral stressors (fasting, exercise, temperature variation); modern lifestyle suppresses these signals
- physical inactivity — sedentary behavior suppresses MDP expression, contributing to metabolic disease through loss of mitochondrial signaling